Figure 1. Stability of oral (methyl)ergometrine least and most harmful conditions

active ingredient (% of stated amount)

Figure 2. Stability of oral (methyl)ergometrine influence of humidity

active ingredient (% of stated amount)

Figure 3. Stability of oral (methyl)ergometrine influence of light

active ingredient (% of stated amount)

Figure 4. Stability of buccal (desamino)oxytocin least and most harmful conditions

active ingredient (% of stated amount)

Figure 5. Stability of buccal (desamino)oxytocin influence of humidity

active ingredient (% of stated amount)

Figure 6. Stability of buccal (desamino)oxytocin influence of light

active ingredient (% of stated amount)

Figure 7. Buccal OT, Dark, 30°, 75% influence of package

active ingredient (% of stated amount)